CTx001 is an investigational AAV-based gene therapy designed to modulate multiple pathways of the complement system Opti-GAIN is a first-in-human trial to evaluate the safety, tolerability, and ...

Opti-GAIN is a first-in-human trial to evaluate the safety, tolerability, and preliminary efficacy of CTx001 as a potential one-time treatment for GA Opti-GAIN builds on insights from i-GAIN, a ...

The Pac-12 has undergone as bigger shuffle than any other as the conference-realignment era of college athletics has shaken up countless programs around the country. Oregon State and Washington State ...

Grammarly built its reputation on being a tool for checking spelling, grammar, and writing tips in English. The company is now expanding the scope of these features to support five more languages: ...

Vanguard Extended Market ETF VXF tracks a total market index that excludes S&P 500 stocks. It’s a misfit in the mid-cap blend category, but it pairs well with a fund that tracks the S&P 500 index to ...

Sitala Bio Ltd. has divulged complement factor B (CFB) inhibitors reported to be useful for the treatment of age-related macular degeneration, schizophrenia, atypical hemolytic uremic syndrome, ...

SAP announced its intent to acquire SmartRecruiters, a leading talent acquisition (TA) software provider, enabling the company to strengthen SAP’s all-in-one HCM suite, so customers have the tools ...

Our free DNA Reverse Complement tool is an indispensable utility for researchers, students, and technicians in molecular biology and genomics. Whether you’re designing PCR primers, verifying ...

Urban Sky develops small stratospheric balloons that can complement or replace satellites. Credit: Urban Sky WASHINGTON — Stratospheric ballooning company Urban Sky has won a contract from the U.S.